Login
$DERM
$3.80 +$0.10 (2.7%) After hours

$DERM SEC Filings

Filed On Filing
12 Nov 2026 10-Q
12 Nov 2026 8-K: Results of Operations and Financial Condition
09 Oct 2026 SCHEDULE 13G/A
12 Aug 2026 10-Q
12 Aug 2026 8-K: Results of Operations and Financial Condition

Total revenues were $18.5 million for the second quarter of 2026, reflecting 23% growth from the prior-year quarter

31 Jul 2026 SCHEDULE 13G/A
15 Jul 2026 SCHEDULE 13G/A
02 Jul 2026 Form 4: Toledano Miranda Jayne, Director

Received 50,000 shares as a grant or award

02 Jul 2026 Form 4: Smith Justin Adam, Director

Received 50,000 shares as a grant or award

02 Jul 2026 Form 4: Herskowitz Neil, Director

Received 50,000 shares as a grant or award

29 Jun 2026 Form 4: Toledano Miranda Jayne, Director

Received 10,000 shares as a grant or award

26 Jun 2026 Form 4: Smith Justin Adam, Director

Received 10,000 shares as a grant or award

26 Jun 2026 Form 4: Herskowitz Neil, Director

Received 10,000 shares as a grant or award

26 Jun 2026 Form 4: Pearce Michael Cooper, Director

Received 10,000 shares as a grant or award

26 Jun 2026 Form 4: Rosenwald Lindsay A Md, Director

Received 10,000 shares as a grant or award

26 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 24, 2026, Journey Medical Corporation (the “Company”) held its 2026 Annual Meeting at 11:00 a.m. Eastern Time by means of an online virtual meeting platform. Stockholders representing 16,145,526 shares of common stock, par value ...

13 May 2026 10-Q
13 May 2026 8-K: Results of Operations and Financial Condition

Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million

30 Apr 2026 DEFA14A
30 Apr 2026 Proxy statement: annual meeting

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support